Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

about

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Item

http://www.wikidata.org/entity/Q48364519

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@en

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@nl

type

Item

label

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@en

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@nl

prefLabel

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@en

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@nl

P1476

Evaluation of the EGFR polymor ...... reated breast cancer patients.

@en

P2093

Esther H Lips

http://www.w3.org/2001/XMLSchema#string

Hayra de Andrade Vieira-Monteiro

http://www.w3.org/2001/XMLSchema#string

Jelle Wesseling

http://www.w3.org/2001/XMLSchema#string

Lennart Mulder

http://www.w3.org/2001/XMLSchema#string

Marjanka K Schmidt

http://www.w3.org/2001/XMLSchema#string

Sten Cornelissen

http://www.w3.org/2001/XMLSchema#string

P2860

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Chemotherapy in early breast cancer: when, how and which one?

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

P304

e0189750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0189750

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosane Vianna-jorge

Daniely Regina Freitas-Alves

Marcelo Sobral-Leite

Letícia Carlos Giacomin

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29267323

http://www.w3.org/2001/XMLSchema#string

P932

5739423

http://www.w3.org/2001/XMLSchema#string